| Identification |
| Name: | 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl5-[(2E)-3-phenyl-2-propen-1-yl] ester |
| Synonyms: | 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl(2E)-3-phenyl-2-propenyl ester (9CI);3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 3-phenyl-2-propenyl ester,(E)-;FRC 8411;OPC 13340; |
| CAS: | 99522-79-9 |
| Molecular Formula: | C25H24N2O6 |
| Molecular Weight: | 448.473 |
| InChI: | InChI=1/C25H24N2O6/c1-16-21(24(28)32-3)23(19-12-7-13-20(15-19)27(30)31)22(17(2)26-16)25(29)33-14-8-11-18-9-5-4-6-10-18/h4-13,15,23,26H,14H2,1-3H3/b11-8+ |
| Molecular Structure: |
 |
| Properties |
| Flash Point: | 328.1°C |
| Boiling Point: | 618.9°Cat760mmHg |
| Density: | 1.253g/cm3 |
| Refractive index: | 1.606 |
| Appearance: | yellow solid |
| Flash Point: | 328.1°C |
| Usage: | A novel calcium channel antagonist; cardiovascular agent. |
| Safety Data |
| |
 |
